BRK-B vs BTO

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 5/9, indicating stable financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. BTO trades at a significant discount to the Graham Number ($77.36) with a current price of $36.94, suggesting deep value characteristics, yet the extremely high forward P/E of 307.83 raises sustainability concerns. Strong profitability metrics like a 593.63% profit margin and 25.45% ROE are offset by weak technical trends (10/100) and liquidity risks from a 0.08 current ratio. The 6.96% dividend yield with a low 32.7% payout ratio supports income appeal, but lack of analyst coverage and insider enthusiasm (40/100) limits conviction.